Delivery Order SPE2DR25D1205-SPE2DR26F1HP5
Award Date 5/12/26
Potential Completion Date 5/13/26
Potential Value $7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $3,130.62 delivery order to Amerisourcebergen Drug Corp on May 6, 2026, for VEMLIDY 25 mg tablets. Place of performance is Conshohocken, PA. Ultimate completion date is May 7, 2026. The order is firm fixed-price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying the Defense Logistics Agency under standing indefinite delivery contracts for military healthcare supply.
- The Defense Logistics Agency issued a $11,634.03 delivery order to Amerisourcebergen Drug Corp on May 6, 2026, for VEMLIDY 25 MG tablets (30-count unit of use packaging), with ultimate completion May 7, 2026. This is a firm fixed-price pharmaceutical delivery order. Place of performance is Conshohocken, PA. The order carries no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and serves as the execution entity for DLA pharmaceutical distribution, operating as a...
- The Defense Logistics Agency issued a $2,704.94 delivery order to Amerisourcebergen Drug Corp on May 8, 2026, for VEMLIDY 25 MG tablets (UU 30s) with an ultimate completion date of May 11, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to...
- The Defense Logistics Agency issued a $3,652.48 delivery order to Amerisourcebergen Drug Corp on May 8, 2026, for VEMLIDY 25 mg tablets (30-count units) with an ultimate completion date of May 11, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., operating as a pharmaceutical distributor and medical supplier delivering brand-name and generic medications, specialty pharmaceuticals,...
- The Defense Logistics Agency issued a $12,331.61 delivery order to Amerisourcebergen Drug Corp on May 1, 2026, for VEMLIDY 25 MG tablets (30-count unit of use packaging). The order closes May 4, 2026. Amerisourcebergen Drug Corp is a pharmaceutical distributor and medical supplier subsidiary of Cencora, Inc. Place of performance is Conshohocken, PA. The order is priced firm fixed-price with no set-aside used. This delivery order is issued against the awardee's parent indefinite delivery contract...
- The Defense Logistics Agency issued a $3,126.96 delivery order to Amerisourcebergen Drug Corp on May 6, 2026, for VEMLIDY 25 MG tablets (30-count unit dose), firm fixed-price, with completion by May 7, 2026. Place of performance is Conshohocken, PA. The order carries no set-aside. Amerisourcebergen Drug Corp operates as a pharmaceutical distributor subsidiary of Cencora, Inc., supplying brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to Defense Health...
- The Defense Logistics Agency issued a $12,529.65 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for VEMLIDY 25 mg tablets (30-count units). The order is issued under a single-award indefinite delivery contract (SPE2DX) with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply. Place of performance is Conshohocken, PA. The order carries a firm...
- The Defense Logistics Agency issued a $33,040.30 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for VEMLIDY 25 mg tablets (30-count units). The order was placed under the Defense Logistics Agency Troop Support Medical IDC, a single-award indefinite delivery contract supporting pharmaceutical and medical supply distribution to military healthcare systems globally. Place of performance is Conshohocken, PA. The ultimate completion date is April 28, 2026. Pricing is firm fixed...
- The Defense Logistics Agency issued a $13,931.26 delivery order to Amerisourcebergen Drug Corp on April 8, 2026, for VEMLIDY 25 mg tablets (30-count unit of use packaging). The order is a call against the parent IDC held by Cencora, Inc. (Amerisourcebergen's parent) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing with no set-aside applied. Ultimate completion date is April 9,...
- <p>The Defense Logistics Agency issued a $1,694.16 delivery order to AmerisourceBergen Drug Corp on May 6, 2026, for VEMLIDY 25 MG tablets (30-count unit dose) with an ultimate completion date of May 7, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is a firm fixed-price purchase under DLA's pharmaceutical supply contracting authority. No set-aside was used.</p>
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1HP5Delivery Order
The Defense Logistics Agency issued a $7,009.82 delivery order to Amerisourcebergen Drug Corp on May 12, 2026, for VEMLIDY 25 MG tablets (30-count units), with an ultimate completion date of May 13, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., operating as a pharmaceutical distributor and medical supplier to federal defense and healthcare systems. The company holds a single-award indefinite delivery contract (SPE2DX) with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.
Generated 8/10/26, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 5/11/26 |